-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA PHARMA CO. - TARGETS REGULATORY APPROVAL IN SOUTH KOREA IN 2027, COMMERCIAL LAUNCH IN 2028

Reuters·10/22/2026 07:12:06